Shared on07 May 25Fair value Decreased 3.06%
AnalystLowTarget made no meaningful changes to valuation assumptions.
Rising Expenses Will Squeeze Margins In US Insurance
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 11 Analysts
Published
29 Apr 25
Updated
07 May 25
AnalystLowTarget's Fair Value
US$31.00
30.9% overvalued intrinsic discount07 May
US$40.57
1Y
29.9%7D
6.1%